IDenta Corp. (IDTA)
USD 0.45
(0.0%)
USD 0.45
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 789.14 Thousand USD | -3.8% |
| 2022 | 820.27 Thousand USD | 60.33% |
| 2021 | 511.63 Thousand USD | 5.8% |
| 2020 | 483.6 Thousand USD | -11.38% |
| 2019 | 545.73 Thousand USD | 18.42% |
| 2018 | 460.82 Thousand USD | -9.16% |
| 2017 | 507.29 Thousand USD | 5.95% |
| 2016 | 478.82 Thousand USD | 208.64% |
| 2015 | 155.14 Thousand USD | 6.63% |
| 2014 | 145.48 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 711.56 Thousand USD | -5.45% |
| 2024 Q1 | 752.55 Thousand USD | -4.64% |
| 2023 Q4 | 789.14 Thousand USD | 134.41% |
| 2023 Q1 | 822.37 Thousand USD | 0.26% |
| 2023 Q2 | 804.5 Thousand USD | -2.17% |
| 2023 FY | 789.14 Thousand USD | -3.8% |
| 2023 Q3 | 336.64 Thousand USD | -58.15% |
| 2022 Q3 | 534.91 Thousand USD | 4.82% |
| 2022 FY | 820.27 Thousand USD | 60.33% |
| 2022 Q1 | 522.26 Thousand USD | 2.08% |
| 2022 Q2 | 510.32 Thousand USD | -2.28% |
| 2022 Q4 | 820.27 Thousand USD | 53.35% |
| 2021 Q1 | 466.34 Thousand USD | -3.57% |
| 2021 FY | 511.63 Thousand USD | 5.8% |
| 2021 Q4 | 511.63 Thousand USD | -6.57% |
| 2021 Q3 | 547.58 Thousand USD | 9.25% |
| 2021 Q2 | 501.24 Thousand USD | 7.48% |
| 2020 Q2 | 536.21 Thousand USD | 1.36% |
| 2020 Q1 | 529.01 Thousand USD | -3.06% |
| 2020 Q3 | 451.84 Thousand USD | -15.73% |
| 2020 FY | 483.6 Thousand USD | -11.38% |
| 2020 Q4 | 483.6 Thousand USD | 7.03% |
| 2019 Q4 | 545.73 Thousand USD | 10.37% |
| 2019 Q1 | 473.98 Thousand USD | 2.86% |
| 2019 Q2 | 481.09 Thousand USD | 1.5% |
| 2019 FY | 545.73 Thousand USD | 18.42% |
| 2019 Q3 | 494.46 Thousand USD | 2.78% |
| 2018 Q2 | 472.68 Thousand USD | 85.83% |
| 2018 FY | 460.82 Thousand USD | -9.16% |
| 2018 Q4 | 460.82 Thousand USD | -3.54% |
| 2018 Q3 | 477.73 Thousand USD | 1.07% |
| 2018 Q1 | 254.36 Thousand USD | -49.86% |
| 2017 FY | 507.29 Thousand USD | 5.95% |
| 2017 Q4 | 507.29 Thousand USD | 0.0% |
| 2016 FY | 478.82 Thousand USD | 208.64% |
| 2015 FY | 155.14 Thousand USD | 6.63% |
| 2014 FY | 145.48 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.24 Million USD | 64.77% |
| Arrayit Corporation | 1.07 Million USD | 26.807% |
| Atlantic International Corp. | 2.93 Million USD | 73.071% |
| Biocept, Inc. | 12.1 Million USD | 93.483% |
| Bioqual, Inc. | 3.58 Million USD | 78.0% |
| CardioGenics Holdings Inc | 72.61 Thousand USD | -986.768% |
| DermTech, Inc. | 54.39 Million USD | 98.549% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 99.833% |
| HTG Molecular Diagnostics, Inc. | 4.83 Million USD | 83.675% |
| iMD Companies, Inc. | 1.12 Million USD | 29.55% |
| Interpace Biosciences, Inc. | 11.19 Million USD | 92.949% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 43.84 Thousand USD | -1699.854% |
| Lumos Diagnostics Holdings Limited | 8.04 Million USD | 90.191% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 3.82 Million USD | 79.374% |
| NovelStem International Corp. | 3.57 Million USD | 77.924% |
| Optigenex Inc. | 8.94 Million USD | 91.174% |
| PharmChem, Inc. | 77.35 Thousand USD | -920.188% |
| Proteome Sciences plc | 17.15 Million USD | 95.4% |
| Response Genetics, Inc | 6.37 Million USD | 87.617% |
| Rennova Health, Inc. | 15.32 Million USD | 94.852% |
| RushNet, Inc. | 4.82 Million USD | 83.638% |
| ScreenPro Security Inc. | 207.03 Thousand USD | -281.167% |
| Stella Diagnostics Inc. | 6.2 Million USD | 87.273% |
| StageZero Life Sciences Ltd. | 1.8 Million USD | 56.161% |
| Todos Medical Ltd. | 38.34 Million USD | 97.942% |